Giant cell arteritis (GCA) is a common type of vasculitis and may present various forms. Ischemic stroke is one of the complications and sometimes the first symptom of this disease. We want to present the case of a 58-year-old female patient with suspected GCA who suffered from recurrent ischemic strokes due to progressive stenosis of the internal carotid arteries. This site of manifestation is rare but indicative of GCA. The patient was first treated with corticosteroids and methotrexate later with tocilizumab. Facing progressive hemodynamic impairment, an extra-intracranial-bypass-surgery was performed. Although inflammatory activity was reduced, new strokes occurred.
Introduction
Giant cell arteritis (GCA) is one of the most common types of vasculitis. It primarily affects the aorta and its extracranial branches [1] . Diagnosis can be challenging due to a variable presentation concerning both clinical and radiological findings. Ischemic stroke is a complication of GCA, occurring in about 4-16% of the patients (partly depending on the conditions under which the strokes were considered GCA-related) [2] [3] [4] [5] [6] . Although in most studies, an obligatory inclusion criterion is temporal-artery-biopsy-proven (TAB)-GCA [3, 7] or GCA diagnosis according to ACR criteria (see Table 1 ), this disease can occur without STA-involvement and new onset headache, scalp tenderness, jaw claudication, or loss of vision [1, 8] . Thus diagnosis might be delayed. Involvement of other vessels like internal carotid arteries (ICA) or vertebral arteries might cause ischemic strokes as a first symptom of the disease [9] . Vascular imaging can be a helpful instrument particularly in the context of a negative TAB or missing STA involvement. Stenosis or parietal thickening of inflammatory vascular origin, particularly of the carotid or vertebral arteries, seems to play an important role in the occurrence of ischemic strokes, since they can be found in many cases with GCA-related ischemic complications [9, 10] .
Case Report
A 58-year-old female patient was admitted to the emergency room complaining of sudden onset palsy of the left arm and leg. The day before, she had had a short transient palsy of the left arm. No headache was present. She had a history of hypertension, hypothyroidism, depression with an onset 2 years prior to the initial hospital admission and a facial nerve palsy around 30 years before. Later, we diagnosed diabetes mellitus type 2 and dyslipidemia. Previous medication included metoprolol, felodipine, duloxetine, and L-thyroxine.
Within the last months before the admission, the patient did not suffer any weight loss, denied night sweats, fever, and headache or other pain.
At the first examination in our emergency room, we saw a left-sided brachyfacial palsy, a positive left Babinski sign but no sensory disturbance or other neurological deficits. Blood pressure was 150/90 mmHg, heart rate 94 bpm. Electrocardiogram showed a left axis deviation and sinus rhythm.
CT-angiography and MRI/MR-angiography revealed stenosis of both intracranial ICA pronounced on the right side ( Fig. 1) , a perfusion deficit of the right hemisphere, and bilateral new infarcts also pronounced on the right side. There was no sign for a dissection. A conventional angiography showed smooth and mostly concentric bilateral distal ICA-stenosis, a 70% stenosis of the right ICA in the C3-C6 segments and a 60% stenosis of the left ICA in the same segments.
Laboratory investigation revealed an elevated ESR (99 mm/h), C-reactive protein (79 mg/L), and ANA-titer (1:640). A large variety of antibodies found in rheumatic diseases repeatedly tested negative including anti-Sjogren-antibodies A/B, nucleosome-, histone-, Ro-52-, RNP-, Mi2-α/β-, Ku-Centromere A/B-, Sp100-, PML-, Scl-70-, PM-Scl-100/75-, RP-, GP210-, PCNA-, DFS70-, GBM-antibodies, DS-DNA-, cardiolipin-, CCP-, antimitochondrial antibodies, and ANCA (antibodies against myeloperoxidase and proteinase3). CSF was normal. There was a mild anemia (hemoglobin 6.9 mmol/L). Testing for HIV and hepatitis B/C was unremarkable. No other cause for ischemic strokes such as atrial fibrillation could be found.
There were no symptoms like tenderness of both STA, painful mouth sores, ulcers, skin-, joint-, genital or eye-involvement. A pathergy test was negative. CSF repeatedly did not show any signs of inflammation. Again, after further testing, there was no proof of a viral or bacterial cause particularly because steroid treatment did not cause any new symptoms or disease progression. Fibromuscular dysplasia was unlikely due to constantly elevated parameters of inflammation and stenoses without "string-of-beads." There were no abnormal vascular networks in the vicinity of the occlusive or stenotic lesions attributable to Moyamoya disease [11] . A whole-body PET-CT in search of a tumor or other inflamed areas was unrevealing however, it was performed while receiving steroid treatment.
Due to missing clinical signs of vasculitis, the patient was dismissed given continuous antiaggregating therapy, a statin, metformin, and sent to neurorehabilitation. A follow-up visit 6 months later was arranged.
Although during that next hospital stay the patient did not complain of any new symptoms, MRI showed new infarcts on the right side and an occlusion of the right ICA (Fig. 2) . Again, no headache was reported; duplex-sonography did not show halo sign or stenosis of either STA (superficial temporal artery). Inflammatory parameters were still elevated (ESR 112 mm/h, CRP 105 mg/L). A temporal artery biopsy (TAB) on the right side including brain parenchyma and dura mater biopsy was performed showing no results of inflammation. A biopsy of the stenotic or occluded carotid artery region was not feasible. Suspecting CGA and facing progressive ischemic strokes and vessel stenoses, we decided to start a steroid treatment under which blood sedimentation rate and CRP decreased.
At that time, no contrast-enhanced MRI was available. Nine months after the first hospital admission and still under corticoid treatment, an MR-angiography ("black-blood imaging sequence") revealed left-sided ICA vessel wall enhancement of the cavernous and petrosal segments (Fig. 3) which can be considered a proof of CGA in that context. Several months later, the patient was emergently presented to our hospital because of new sensorimotor disturbances on the right side. We decided to discuss this case with our neurosurgery colleagues who performed an extra-intracranial bypass surgery due to severe hemodynamic impairment of both hemispheres at which a radial artery autograft was inserted between a medial cerebral artery branch and the external carotid artery close to the carotid bulb.
Following several months of neurorehabilitation, the patient received treatment with methotrexate and corticosteroids. Several months later, after trying to reduce the dose of corticosteroids, the patient was presented again to the emergency room two different times with new bilateral frontal infarcts and now bilateral ICA occlusions. A duplex sonography still showed a large contribution of the bypass to the left hemisphere's perfusion. The right hemisphere is predominantly supplied by the posterior circulation. We began a medication with tocilizumab. However, partly attributable to a hemodynamic mechanism new strokes occurred. To date, the patient has e palsy of the left arm, neurocognitive disturbances, and needs nursing care.
Discussion
We present a patient with GCA and rapidly progressive vessel stenoses despite intensive immunosuppressive therapy plateauing in occlusion of both ICA which led to strokes and hemodynamic impairment.
Although ICA-involvement has been reported before as a rare but characteristic pattern in GCA, especially in the petrous and cavernous segments [12, 13] , to our knowledge this is the first reported case of a patient with GCA, recurrent bihemispheric strokes, and no other vessel involvement than both intracranial/extradural ICA. Our literature research did not provide comparable cases regarding the location of stenosis and occurrence of ischemic strokes in other categories of vasculitis (Takayasu arteritis, polyarteritis nodosa, ANCA-associated small vessel vasculitis, PACNS, etc.).
It seems that involvement of carotid and vertebral arteries adds to the risk of ischemic strokes in GCA [9, 10] . We did not find data proving that the degree of inflammatory vascular stenosis influences the amount and severity of ischemic strokes by mechanisms beyond hemodynamics.
We concur with previous findings that this unusual manifestation of GCA only in the ICA caused a lower chance of developing headache or jaw claudication [14] and is a reason why our patient could not be diagnosed according to ACR-criteria (Table 1) , since initially only elevated ESR and age >50 years were present. Even more proper imaging (MRI e.g., black-blood imaging sequence or PET-CT) is needed to search for vasculitis in the case of clinically suspected GCA in order to initiate early immunosuppressive therapy.
Another particularity of this case is the combined pharmaceutical and surgical treatment with an extra-intracranial bypass. There are previous cases in which patients with GCA and distal ICA occlusions received an STA-MCA bypass [15] or bypass plus EMS [16] . To our knowledge, this is the first case with a successfully performed high-flow autograft-extra/intracranial bypass in a patient with GCA. Performance of this procedure is an invasive but beneficial option for a well selected group of patients that face progressive hemodynamic impairment and ischemic strokes.
Along with our case in previous studies, diabetes, arterial hypertension, and hyperlipidemia were more common in GCA patients developing stenosis rather than in GCA patients without stenosis [6, 7] thus atherosclerosis might contribute to the mechanisms causing ischemic strokes in GCA patients. An emphasized treatment of these risk factors should be considered equally as important as in patients with ischemic strokes of sole atherosclerotic origin.
In a large observational cohort study, the risk of an ischemic stroke was nearly 5 times higher in the first month after the diagnosis of CGA compared to control data base patients and only 27% higher in a total follow-up period of several years (median follow-up time 3.9 years) [4] which is probably attributable to medical treatment. These findings might possibly be applicable to GCA flares where similar discoveries were made [9] . In our present case, this link was also to be assumed, since new ischemic strokes occurred after reducing the dose of corticosteroids.
Conclusion
Our aim is to depict the challenges of diagnosing a common but variously presenting disease following established criteria. It is self-evident that there are exceptional clinical courses of GCA differing from the 'classic' ones in terms of key signs and symptoms which necessitates a wide and careful search for other diseases explaining the symptoms. A comparison with similar cases can provide a clue to find the right diagnosis. Eventually an early diagnosis of this disease is beneficial for the patient, since by starting immunotherapy, complications like ischemic strokes can potentially be avoided. 
